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ABSTRACT
Human kidney predominant protein, NCU-G1, is a highly conserved
protein with an unknown biological function. Initially described as a
nuclear protein, it was later shown to be a bona fide lysosomal
integral membrane protein. To gain insight into the physiological
function of NCU-G1, mice with no detectable expression of this gene
were created using a gene-trap strategy, and Ncu-g1gt/gt mice were
successfully characterized. Lysosomal disorders are mainly caused
by lack of or malfunctioning of proteins in the endosomal-lysosomal
pathway. The clinical symptoms vary, but often include liver
dysfunction. Persistent liver damage activates fibrogenesis and, if
unremedied, eventually leads to liver fibrosis/cirrhosis and death. We
demonstrate that the disruption of Ncu-g1 results in spontaneous liver
fibrosis in mice as the predominant phenotype. Evidence for an
increased rate of hepatic cell death, oxidative stress and active
fibrogenesis were detected in Ncu-g1gt/gt liver. In addition to collagen
deposition, microscopic examination of liver sections revealed
accumulation of autofluorescent lipofuscin and iron in Ncu-g1gt/gt
Kupffer cells. Because only a few transgenic mouse models have
been identified with chronic liver injury and spontaneous liver fibrosis
development, we propose that the Ncu-g1gt/gt mouse could be a
valuable new tool in the development of novel treatments for the
attenuation of fibrosis due to chronic liver damage.
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INTRODUCTION
Human kidney predominant protein, NCU-G1, is a protein whose
function is only beginning to emerge. First reported in 1994 (Eskild
et al., 1994), mouse NCU-G1 was cloned in 2001 (Kawamura et al.,
2001). Initial studies described NCU-G1 as a nuclear protein with
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gene regulatory properties (Steffensen et al., 2007), whereas more
recent reports have shown that NCU-G1 is a bona fide lysosomal
type I integral membrane protein (Sardiello et al., 2009; Schieweck
et al., 2009; Schröder et al., 2010). NCU-G1 is highly conserved,
proline-rich and ubiquitously expressed; however, it shows no
sequence homology to other known proteins.
The endosomal-lysosomal pathway is sensitive to protein
dysfunctions, and alterations in protein composition and function
can lead to a group of metabolic diseases categorized as lysosomal
disorders (Futerman and van Meer, 2004; Parkinson-Lawrence et al.,
2010). Intralysosomal accumulation of unmetabolized substrates can
result from malfunction of any endosomal-lysosomal protein, but the
severity and clinical manifestations vary owing to secondary
alterations in other biochemical and cellular pathways (Futerman
and van Meer, 2004), such as apoptosis and elevated levels of
reactive oxygen species due to impaired lysosomal clearance of
damaged organelles through autophagy (Tardy et al., 2004; Kiselyov
et al., 2007; Kurz et al., 2008; Cox and Cachón-González, 2012).
Certain cell types are more sensitive to lysosomal dysfunction than
others, especially cells with low proliferation capacity (Kiselyov et
al., 2007; Kurz et al., 2008; Cox and Cachón-González, 2012). This
is reflected in the vast frequency of neurological symptoms in
different lysosomal disorders (Parkinson-Lawrence et al., 2010; Cox
and Cachón-González, 2012; Platt et al., 2012). For some disorders,
however, other symptoms like liver damage are also a consistent
clinical finding (Platt et al., 2012).
Persistent injury to the liver eventually leads to liver fibrosis and
deposition of excess connective tissue (Bataller and Brenner, 2005;
Friedman, 2008; Gieling et al., 2008; Kisseleva and Brenner, 2011;
Ramachandran and Iredale, 2012). The development of liver fibrosis
involves several liver cell types and immune cells, including
hepatocytes, hepatic stellate cells (HSCs), Kupffer cells (KCs),
endothelial cells and infiltrating leukocytes (Friedman, 2008;
Pinzani and Macias-Barragan, 2010; Hernandez-Gea and Friedman,
2011). Dying cells secrete reactive oxygen species, and release
necrotic and apoptotic fragments, leading to activation of KCs and
recruitment of inflammatory cells to the site of injury (Bataller and
Brenner, 2005; Friedman, 2008). Activated KCs and recruited
leukocytes contribute to the activation of HSCs into myofibroblast-
like cells by secreting pro-fibrogenic cytokines, including
transforming growth factor-β (TGF-β) and platelet-derived growth
factor (PDGF) (Bataller and Brenner, 2005; Friedman, 2008). When
activated, HSCs start secreting high amounts of extracellular matrix
(ECM) proteins that differ from those normally expressed, including
fibrillar collagen, thus replacing dead parenchymal cells with fibrous
ECM, ultimately compromising the organ function if untreated
(Gressner et al., 2007; Mormone et al., 2011).
Loss of lysosomal membrane protein NCU-G1 in mice results in
spontaneous liver fibrosis with accumulation of lipofuscin and iron
in Kupffer cells
Xiang Y. Kong1,*, Cecilie Kasi Nesset1,*, Markus Damme2,3,*, Else-Marit Løberg4, Torben Lübke3, Jan Mæhlen4,
Kristin B. Andersson5, Petra I. Lorenzo1, Norbert Roos1, G. Hege Thoresen6,7, Arild C. Rustan6, Eili T. Kase6
and Winnie Eskild1,‡
D
is
ea
se
 M
od
el
s 
&
 M
ec
ha
ni
sm
s
352
Several rodent models for inducible liver fibrosis are available
(Weiler-Normann et al., 2007; Starkel and Leclercq, 2011), but only
a few transgenic mouse models have been identified that develop
spontaneous liver fibrosis (Fickert et al., 2002; Takehara et al., 2004;
Wandzioch et al., 2004; Warskulat et al., 2006). Mouse models are
widely used in the study of lysosomal disorders and the impact of
lysosomal protein deficiency (Parkinson-Lawrence et al., 2010; Platt
et al., 2012). However, the physiological consequences of loss of
NCU-G1 function have never been characterized before. The
lysosomal localization suggests some alterations in the endosomal-
lysosomal pathway following Ncu-g1 gene disruption. In this article,
we present a new mouse model, created by using a gene-trap
strategy to introduce a transcriptional stop codon to intron 1 of the
Ncu-g1 gene (Ncu-g1gt/gt). Ncu-g1gt/gt mice have no detectable
expression of NCU-G1, display normal growth and fertility, and
have a life expectancy up to at least 18 months. The predominant
phenotype is a spontaneous development of liver fibrosis by the age
of 6 months. Analyses of Ncu-g1gt/gt liver indicate that absence of
this lysosomal membrane protein leads to an increased rate of
hepatic cell death, oxidative stress, activation of the fibrogenic
response, and accumulation of lipofuscin and iron in KCs.
RESULTS
Successful generation of Ncu-g1gt/gt mice
Breeding of heterozygous mice carrying a gene-trap cassette inserted
into intron 1 of the Ncu-g1 gene (Fig. 1A) resulted in three expected
genotypes (Ncu-g1wt/wt, Ncu-g1wt/gt and Ncu-g1gt/gt) (Fig. 1B).
Expression of mRNA for Ncu-g1 was analyzed to assess any
transcription leakage from the gene-trap. Fig. 1C shows a total
elimination of Ncu-g1 mRNA in homozygous gene-trap mice
compared with wild-type mice in all organs studied. Lysosome-
enriched fractions from mouse liver after tyloxapol treatment
(Schieweck et al., 2009) were used to confirm the loss of NCU-G1
at the protein level as shown in Fig. 1D. Genotype and sex
distributions for a total of 364 pups generated by four heterozygous
breeding pairs were analyzed and found to be in accordance with
Mendelian distributions (P<0.001), indicating that NCU-G1 was not
essential for mouse embryonic development (data not shown).
Heterozygotes and homozygotes had similar growth rates as their
wild-type siblings. When mated, homozygous Ncu-g1gt/gt mice
produced litters at the same frequency and of a similar litter size as
wild-type and heterozygote mating (data not shown).
Phenotype of Ncu-g1gt/gt mice
At birth, Ncu-g1gt/gt mice were indistinguishable from wild-type
siblings, and displayed no obvious behavioral differences. At the age
of 6 months, lack of NCU-G1 resulted in a fibrotic appearance of
the liver, with large nodules on the surface (Fig. 2A). However, the
liver:body weight ratio was unaffected (Fig. 2A). Splenomegaly was
observed in Ncu-g1gt/gt mice with a nearly doubled spleen:body
weight ratio (Fig. 2B). This is probably a result of portal vein
hypertension caused by the liver fibrosis. Measurements of serum
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) activities showed moderate but significant increases in Ncu-
g1gt/gt mice compared with wild-type animals (Fig. 2C). Other
organs (kidney, lung, heart, brain) appeared normal and were not
further evaluated in this study. Interestingly, Ncu-g1gt/gt mice were
kept until the age of 18 months before termination, indicating that
the liver fibrosis does not progress to a lethal condition during this
period.
Inflammation and excess collagen in Ncu-g1gt/gt liver
In order to gain insight into the underlying mechanisms behind the
Ncu-g1gt/gt mouse phenotype, qPCR arrays were used to identify
changes in gene expression in groups of genes known to be involved
in liver fibrogenesis. This initial screening suggested that genes
associated with fibrosis, hepatotoxicity and oxidative stress
responses were regulated in Ncu-g1gt/gt liver (supplementary material
Table S1). In addition, a screening of different signal transduction
pathways suggested a strong upregulation of genes encoding
chemokines and proteins involved in control of the cell cycle
(supplementary material Table S1). A selection of these genes was
verified by qPCR (see below).
Light-microscopic examination of hematoxylin and eosin (H&E)-
stained liver sections from Ncu-g1gt/gt mice showed infiltration of
mononuclear leukocytes and granulocytes in the portal areas with
some piecemeal necrosis (Fig. 3A). Widespread deposition of
collagen was revealed in sections stained with Masson-Goldner’s
trichrome (Fig. 3B). This observation was supported by electron
microscopy, showing thick collagen fibers in the space of Disse
(Fig. 3C) and sirius-red quantification of total collagen content in
liver homogenates (Fig. 3D). In affected areas, loss of hepatocytes
and bridging fibrosis resulted in disruption of the normal tissue
architecture (Fig. 3A,C). Expression of genes such as Vcam1, Ccl2
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TRANSLATIONAL IMPACT
Clinical issue
Lysosomal storage disorders are a group of inherited metabolic disorders
that are caused by malfunction of the endosomal-lysosomal pathway,
often with devastating consequences for patients. Most lysosomal
disorders exhibit neurological symptoms, but internal organ injury and
liver damage are consistent clinical findings in several lysosomal
disorders. Indeed, recent research has uncovered a direct link between
abnormal lysosomal function and liver fibrosis – scarring of the liver in
response to chronic injury that eventually leads to liver cirrhosis.
Currently, due to a shortage of more suitable models, the development
of liver fibrosis is often studied in animal models that involve
experimental induction of liver damage, which leads to acute fibrosis. An
animal model of chronic fibrosis is needed to help improve our
understanding of this condition.
Results
Transgenic mouse models of lysosomal disorders are valuable tools for
characterization of the molecular mechanisms behind the broad
spectrum of clinical symptoms, including liver fibrosis. In this study, the
authors develop a novel mouse model with no detectable expression of
the lysosomal membrane protein, NCU-G1, using a gene-trap strategy;
NCU-G1 is highly expressed in liver, kidney, lung and prostate and might
be crucial for normal lysosomal function. The authors report that
disruption of Ncu-g1 in mice does not interfere with fertility, normal
embryonic development or growth. They show that the predominant
phenotype of Ncu-g1gt/gt mice is spontaneous development of liver
fibrosis, accompanied by splenomegaly. Using gene expression
analyses, the authors show that Ncu-g1gt/gt mice exhibit all the hallmarks
of well-established liver fibrosis by the age of 6 months. Finally, they
report that NCU-G1 deficiency leads to accumulation of lipofuscin and
iron in Kupffer cells in the liver.
Implications and future directions
These results indicate that disruption of NCU-G1 function leads to
chronic liver injury and activation of fibrogenesis in mice. Ncu-g1gt/gt mice
therefore represent a potential animal model for studies of these
conditions and for the development of treatments for liver fibrosis. Further
studies using this model will enable a more extensive characterization of
the biochemical and molecular pathways that are affected during chronic
liver damage and fibrogenesis, and will determine whether abnormal
storage of lipofuscin and iron in Kupffer cells is a primary or secondary
effect of NCU-G1 ablation. Finally, these findings suggest that disruption
of Ncu-g1 might be causative for a previously undescribed lysosomal
disorder that has liver fibrosis as its predominant phenotype.
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and Nfkb1, involved in leukocyte recruitment (Fig. 3E), and Mmp2,
Mmp9, Timp1 and Col1a2, involved in ECM remodeling
(Fig. 3F,G), were found to be elevated in Ncu-g1gt/gt liver, as
detected by qPCR analysis, supporting the microscopy findings.
Increased rate of cell death and oxidative stress in Ncu-
g1gt/gt liver
In the Ncu-g1gt/gt livers, scattered acidophilic hepatocytes were seen
(Fig. 3A, insert). Immunoreactivity for active caspase 3, a specific
marker for apoptosis, showed an increased number of apoptotic cells
in Ncu-g1gt/gt mouse liver (Fig. 4A). Increased levels of active
caspase 3 were also confirmed by western blot (Fig. 4B). Leukocyte
infiltration and damage to hepatocytes are often associated with
increased oxidative stress (Friedman, 2008), as already indicated by
qPCR array analyses. Fig. 4C shows the increased levels of
expression of a selection of genes associated with oxidative stress:
iNos2, Gpx3, Sod3 and Noxa1.
Active fibrogenesis in Ncu-g1gt/gt liver
Injury to hepatic cells and oxidative stress are inducers of liver
fibrogenesis, a process that involves several cell types including
KCs, HSCs and recruited leukocytes (Bataller and Brenner, 2005;
Friedman, 2008; Pinzani and Macias-Barragan, 2010; Hernandez-
Gea and Friedman, 2011). KCs can be activated upon liver injury by
phagocytosis of apoptotic bodies (Canbay et al., 2003a). Analyses
of frozen sections from wild-type and Ncu-g1gt/gt livers showed
increased staining for CD68, a marker for activated KCs (Kinoshita
et al., 2010), in Ncu-g1gt/gt livers (Fig. 5A). To further characterize
the KCs, staining for F4/80 revealed swollen and hypertrophic
macrophages (Fig. 5B), displaying a post-phagocytic phenotype.
Because inflammatory macrophages have been shown to switch to
a restorative subset after phagocytosis (Ramachandran et al., 2012),
we investigated the expression of an inflammatory (Cd86) and a
restorative (Cd81) marker (Ramachandran et al., 2012) by qPCR.
Fig. 5C shows a significant increase in Cd86 expression, suggesting
that the activated macrophages in Ncu-g1gt/gt livers belong to a pro-
inflammatory subtype (Ramachandran et al., 2012).
Activated KCs stimulate HSC activation by secreting reactive
oxygen species and pro-fibrotic cytokines, such as TNF-α (Canbay
et al., 2003a), TGF-β and PDGF (Bataller and Brenner, 2005;
Friedman, 2008). Fig. 5D,E show increased expression of mRNA
for all three cytokines in addition to a receptor for TGF-β, thus
confirming activation of KCs. When HSCs are activated by pro-
fibrotic cytokines, they evolve into myofibroblast-like cells and start
expressing α-Sma, Vim, Igfbp3 and collagen (predominantly type
I), characteristic for their activation (Boers et al., 2006; Friedman,
353
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Fig. 1. Verification of Ncu-g1 gene disruption. (A) Schematic representation of gene-trap vector insertion into the Ncu-g1 locus (top). The wild-type (wt)
allele (middle) and the trapped (gt) allele (bottom) are shown. The targeting vector, consisting of a neomycin-resistance cassette (NeoR) and a polyadenylation
site (pA), was inserted into intron 1 of the wt allele to produce a gene-trap (gt) allele. Arrows indicate the hybridization sites for genotyping primers (NCUG1
and FlpROSA, for wt and gt alleles, respectively). PCR products of 562 bp indicate the presence of Ncu-g1 wt allele and 811 bp the gt allele, respectively.
(B) Genotyping of mice by PCR. The Ncu-g1 wt 562 bp PCR product was present in both homozygous wild-type (wt/wt) and heterozygous (wt/gt) samples, but
not in homozygous gene-trap (gt/gt) samples. Conversely, the 811 bp gene-trap PCR product was present in gt/gt and wt/gt samples, but not in wt/wt samples.
(C) The absence of mRNA transcripts in Ncu-g1gt/gt was verified in liver, kidney, lung and spleen, using TaqMan qPCR and Gapdh as a reference gene. (D) No
NCU-G1 protein was detected by western blot analyses of Ncu-g1gt/gt liver tritosomes. Lamp1 served as a loading control.
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2008). This was demonstrated by the increased expression of α-Sma,
Igfbp3 and Vim as shown in Fig. 5F and supported by
immunostaining of liver sections from Ncu-g1gt/gt mice, showing the
presence of star-shaped α-Sma-positive cells in the liver parenchyma
(Fig. 5G). Taken together, these results point to activation of both
KCs and HSCs in Ncu-g1gt/gt liver. When activated, these cells
recruit white blood cells to sites of lesion, depicted in Fig. 3A and
Fig. 4A (Maher, 2001; Bataller and Brenner, 2005; Zhan et al.,
2006). The qPCR arrays suggested a massive increase in the mRNA
levels for myeloperoxidase. This was confirmed at the protein level
by immunofluorescence (Fig. 5H) and verified by qPCR (Fig. 5I).
Myeloperoxidase is most probably produced by the infiltrating
polymorphonuclear leukocytes (Ford, 2010; Amanzada et al., 2011).
This enzyme was found in a clustered distribution in small cells, and
showed a low degree of colocalization with KCs, another cell type
capable of producing this enzyme (Brown et al., 2001)
(supplementary material Fig. S1). In support of these findings, the
mRNA level of S100 calcium binding protein A8 (S100A8), a
protein known to be involved in chemotaxis of polymorphonuclear
leukocytes (Ryckman et al., 2003), was significantly upregulated in
Ncu-g1gt/gt liver (Fig. 5J).
Accumulation of autofluorescent material in Ncu-g1gt/gt
Kupffer cells
Dysfunction of lysosomal proteins is often associated with
intralysosomal storage of undigested material due to impaired
hydrolytic or transport activity (Futerman and van Meer, 2004).
Hence, we investigated the possibility of storage in Ncu-g1gt/gt liver
lysosomes. Fig. 6A shows immunofluorescence staining for Lamp1,
a marker for lysosomes. Lamp1-positive vesicles were massively
enlarged. Fluorescence examination revealed that autofluorescent
material was present in these enlarged Lamp1-coated vesicles, and
colocalized with CD68-positive staining, indicating activated KCs
(supplementary material Fig. S2A). Storage in KCs was confirmed
by electron microscopy, where large storage vacuoles were observed
in this cell type in Ncu-g1gt/gt liver (Fig. 6B). Such structures were
not obviously seen in other cell types (data not shown). Affected
KCs were identified based on morphology after immunoreactivity
for F4/80 (supplementary material Fig. S2B). These cells were also
positively stained with Perls’ Prussian blue (Fig. 6C and
supplementary material Fig. S2B), indicating storage of iron in Ncu-
g1gt/gt liver KCs. Gene expression analyses showed that Ncu-g1
mRNA was expressed in isolated parenchymal as well as non-
parenchymal cells from wild-type liver, ruling out the possibility that
storage in KCs, but not hepatocytes, was a result of a cell-type-
specific lack of Ncu-g1 expression (data not shown). In support of
these findings, the mRNA levels of Hepcidin1 and L-Ferritin,
proteins involved in intracellular iron accumulation (Ganz, 2011),
were shown to be elevated in Ncu-g1gt/gt liver (Fig. 6D). In addition,
the expression of the iron transporter Ferroportin was increased
(Fig. 6D).
Next, we investigated the expression and activity of a selection of
lysosomal enzymes known to be causative for lysosomal disorders.
Immunofluorescence studies of cathepsin D expression showed
colocalization with CD68 in liver sections from wild-type and Ncu-
g1gt/gt mice (supplementary material Fig. S3). However, the overall
expression of cathepsin D was reduced in Ncu-g1gt/gt liver
(supplementary material Fig. S3). This finding was confirmed by
western blot analyses where the expression of full-length cathepsin
D was significantly reduced (Fig. 7A). Cathepsin D reduction has
been shown during the process of tissue regeneration (Suleiman et
al., 1980; Fernández et al., 2004). Chronic liver injury leads to
activation of oval cells after hepatocytes have exhausted their
proliferative capacity (Conigliaro et al., 2010), and might contribute
to the observed increase in Mmp2 and Mmp9 expression as shown
in Fig. 3G (Pham Van et al., 2008). We examined the oval cell
compartment by immunofluorescence labeling for the specific
marker, A6 (Engelhardt et al., 1993). Supplementary material Fig.
S4 shows strongly increased staining for A6 in Ncu-g1gt/gt liver.
Further fluorescence studies indicated that the reduced levels of
cathepsin D in Ncu-g1gt/gt liver are partially due to the increased
number of oval cells, which do not express cathepsin D (Fig. 7B).
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Fig. 2. Loss of NCU-G1 leads to liver fibrosis and splenomegaly in 6-
month-old mice. (A) Representative livers from wild-type (WT) and Ncu-
g1gt/gt mice. Wild-type liver has a smooth surface with easily recognizable
individual lobes, whereas the Ncu-g1gt/gt liver has a fibrotic appearance and a
contracted, distorted and nodular appearance. Disruption of Ncu-g1 did not
result in hepatomegaly, as indicated by the liver weight:body weight ratio
(P=0.23, n=6-7). (B) Representative pictures of a wild-type (WT) and Ncu-
g1gt/gt spleen. Spleen weight:body weight ratio of WT and Ncu-g1gt/gt spleens
shows a significantly enlarged spleen in Ncu-g1gt/gt mice (n=6-7, *P=0.02).
(C) Serum ALT and AST activity levels are significantly elevated in Ncu-g1gt/gt
mice (n=4, *P<0.05). Values are expressed as mean±s.e.m.
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No alterations of other lysosomal enzymes included in this study
were detected (supplementary material Fig. S5).
DISCUSSION
In this study, we have shown that Ncu-g1gt/gt mice were viable and
indistinguishable from wild-type siblings with regard to growth and
fertility. However, lack of NCU-G1 expression led to spontaneous
development of liver fibrosis within 6 months. The Ncu-g1gt/gt mice
showed elevated serum ALT and AST activity levels, increased
deposition of extracellular collagen, activated KCs and HSCs,
infiltrating leukocytes and apoptotic cells. In support of these
findings, the expression of marker genes for oxidative stress and
fibrosis were increased in the Ncu-g1gt/gt liver. These phenotypic
findings are all key elements in liver fibrogenesis (Bataller and
Brenner, 2005; Friedman, 2008; Kisseleva and Brenner, 2008).
Furthermore, autofluorescent lipofuscin and iron accumulated in
Ncu-g1gt/gt liver KCs. Despite ubiquitous expression of Ncu-g1
(Steffensen et al., 2007; Schieweck et al., 2009) and the verified loss
of transcript in all assayed organs, this study suggested that lack of
NCU-G1 predominantly affects the liver. The observed
splenomegaly is likely a secondary effect due to portal vein
hypertension.
Lysosomes are present in nearly every cell of the body, but
pathological manifestations of lysosomal disorders can be restricted
to specific organs as shown for mice with disrupted lysosomal
integral membrane protein 1 (Limp1). These animals are both fertile
and viable and do not present any overt phenotype, but they suffer
from a disturbed water balance, and hence a kidney pathology
(Schröder et al., 2009). Limp1 is ubiquitously expressed, so the
kidney pathology could be a result of an organ-specific function of
355
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Fig. 3. Inflammation, dying hepatocytes and collagen deposition in Ncu-g1gt/gt liver. (A) Hematoxylin and eosin staining of liver sections from 6-month-old
wild-type (WT) and Ncu-g1gt/gt mice with a distorted tissue structure, massive infiltration of mononuclear leucocytes and granulocytes (long arrows), and
acidophilic hepatocytes (short arrows, inset) in portal areas of Ncu-g1gt/gt mice. Scale bar: 50 μm. (B) Masson-Goldner’s trichrome staining of liver sections
from WT and Ncu-g1gt/gt mice shows fibrosis in periportal regions of Ncu-g1gt/gt mice (arrows), where connective tissue stains green. Scale bar: 50 μm.
(C) Representative transmission electron microscopy micrographs of perisinusoidal areas in liver sections from WT and Ncu-g1gt/gt mice. Massive deposition of
fibrous collagen is present in the space of Disse of the Ncu-g1gt/gt liver (arrows) (C, collagen). Scale bars: 2 μm. (D) Relative total collagen content in WT and
Ncu-g1gt/gt liver as measured by sirius-red colorimetric plate assay. (E) qPCR analyses show elevated expression of genes involved in leukocyte recruitment
(Ccl2, Vcam1, Nfkb1), and (F,G) extracellular matrix remodeling (Col1a1, Timp1, Mmp2, Mmp9) in Ncu-g1gt/gt liver (n=4, *P<0.05, **P<0.005, ***P<0.001).
Values are expressed as mean±s.e.m.
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Limp1 that cannot be compensated by other proteins (Schröder et
al., 2009).
The majority of lysosomal disorders are characterized by
intralysosomal accumulation of unmetabolized substrates; however,
secondary alterations in other biochemical and cellular pathways
contribute to a wide range of clinical symptoms (Futerman and van
Meer, 2004). These vary from neurological and developmental
problems to internal organ injury (Jevon and Dimmick, 1998;
Futerman and van Meer, 2004; Parkinson-Lawrence et al., 2010).
Liver fibrosis is a common finding in several lysosomal storage
diseases, including Gaucher disease (James et al., 1981; Lachmann
et al., 2000), cholesteryl ester storage disease (Desai et al., 1987;
Bernstein et al., 2013), and Niemann Pick A/B and C disease (Kelly
et al., 1993; Takahashi et al., 1997). Recent work by Moles et al.
demonstrated a direct link between lysosomal dysfunction and liver
fibrogenesis through the lysosomal enzyme acidic
sphingomyelinase, deficient in Niemann Pick type A/B (Takahashi
et al., 1997). This enzyme regulates fibrogenesis through control of
HSC activation by the lysosomal proteases cathepsins B and D
(Moles et al., 2009; Moles et al., 2010; Moles et al., 2012).
Lysosomal cathepsins play a pivotal role in the execution of
lysosomal cell death (reviewed in detail in Aits and Jäättelä, 2013).
A direct link between hepatocyte cell death and cathepsin B and D
leakage into the cytosol is well established (Roberg et al., 1999;
Guicciardi et al., 2000; Kågedal et al., 2001; Canbay et al., 2003b).
However, in Ncu-g1gt/gt liver the protein levels of cathepsin B and D
are not elevated, indicating that the increased level of cell death and
liver fibrosis observed in Ncu-g1gt/gt mice is not a result of an
increased expression of these proteases. Decreased expression of
cathepsin D has been reported for regenerating liver after partial
hepatectomy, where the hepatocytes proliferate and restore liver
volume within ~10 days (Suleiman et al., 1980; Fernández et al.,
2004). In Ncu-g1gt/gt liver the reduced level of cathepsin D might
result from the observed lack of cathepsin D expression in oval cells.
Oval cells contribute to liver regeneration when the proliferative
capacity of hepatocytes is exhausted or compromised (Conigliaro et
al., 2010), as often seen in conjunction with chronic liver injury
(Roskams et al., 2003; Conigliaro et al., 2010), and their activation
has been shown to be closely related to inflammation and cytokine
production (Knight et al., 2005). Activation of the oval cell
compartment, as seen in the Ncu-g1gt/gt liver, indicates a suppressed
hepatocyte proliferation at 6 months of age. The transgenic insults
in the Ncu-g1gt/gt mouse are chronic and accompanied by massive
infiltration of inflammatory cells, increased apoptosis and elevated
expression of cytokines, yet these mice maintain their liver:body
weight ratio and sufficient liver function to avoid progression to
cirrhosis and death.
Spontaneous development of liver fibrosis in combination with a
similar longevity as for the Ncu-g1gt/gt mice has been demonstrated
in only a few transgenic mouse models. Among these are the Taut−/−
mouse model and the hepatocyte-specific deletions of Bcl-xL or
Mcl-1, all displaying elevated rates of hepatocyte apoptosis as the
fibrogenic inducer (Takehara et al., 2004; Warskulat et al., 2006;
Vick et al., 2009; Weber et al., 2010). Interestingly, the liver integrity
in the Taut−/− mouse is maintained by oval cell proliferation
(Warskulat et al., 2006). The ability of Ncu-g1gt/gt mice to maintain
sufficient liver function and integrity with older age is currently
under investigation.
With regard to putatively affected pathways in which NCU-G1
might be involved, the detection of autofluorescent lipofuscin might
give some clues. Intralysosomal accumulation of unmetabolized
substrates is often caused by deficiencies of soluble enzymes, but
some are caused by dysfunction or absence of transmembrane
proteins, some of which act as exporters of metabolites through the
lysosomal membrane (Futerman and van Meer, 2004). Whether
NCU-G1 with its single transmembrane region (Sardiello et al.,
2009; Schieweck et al., 2009; Schröder et al., 2010) might serve any
export function similar to the Lamp2-mediated cholesterol export
from lysosomes remains to be determined (Schneede et al., 2011).
Lipofuscin is an intralysosomal polymeric material, undegradable
by lysosomal enzymes. It originates from oxidative damage to
macromolecules, often associated with degradation of iron-
containing proteins (Terman and Brunk, 2004). KCs contribute to
the iron metabolism through phagocytosis of erythrocytes (Graham
et al., 2007) and excess storage of heme in KCs has been shown to
promote oxidative stress, increase hepatic inflammation, induce
hepatocyte apoptosis and stimulate fibrogenesis (Otogawa et al.,
2007). In support of the hypothesis that storage material in
phagolysosomes of KCs can be causative for the inflammation
observed in Ncu-g1gt/gt liver, the threefold increase of CD86
expression suggests that the Ncu-g1gt/gt hepatic macrophage subset
is pro-inflammatory (Ramachandran et al., 2012). However, this
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Fig. 4. Increased rate of cell death and oxidative stress in Ncu-g1gt/gt
liver. (A) Liver sections labeled for active caspase 3 and counterstained with
Mayer’s hematoxylin indicate apoptosis (long arrows) and inflammation
(short arrows) in Ncu-g1gt/gt mice. Scale bar: 50 μm. (B) Representative
western blot showing caspase 3 expression in wild-type (WT) and Ncu-g1gt/gt
liver. The levels of active caspase 3 were significantly higher in Ncu-g1gt/gt
liver homogenates (n=4, *P<0.05). (C) Expression of genes involved in
oxidative stress (iNos2, Gpx3, Sod3, Noxa1) were elevated in Ncu-g1gt/gt liver
(n=4, *P<0.05, **P<0.005). Values are expressed as mean±s.e.m.
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result needs to be interpreted with caution, because liver sinusoidal
endothelial cells are also known to express this marker (Knolle et
al., 1998; Knolle and Limmer, 2003).
Ncu-g1gt/gt KCs also show accumulation of iron, as detected by
Perls’ Prussian blue staining, coinciding with an elevated hepatic
expression of the iron storage protein L-Ferritin (Recalcati et al.,
2008). The plasma membrane iron exporter, Ferroportin, is
expressed exclusively by KCs in liver (Knutson et al., 2003), and its
expression is induced by erythrophagocytosis and iron loading
(Knutson et al., 2003). During a state of inflammation, elevated
Hepcidin1 levels target Ferroportin for degradation (Collins et al.,
2008; Ganz, 2011). In agreement with the observed iron
accumulation in KCs, the expression of Hepcidin1 and Ferroportin
was increased in Ncu-g1gt/gt liver. These results also suggest a
possible accumulation of erythrocyte-derived storage material in the
phagolysosomes of Ncu-g1gt/gt KCs. An essential heme transporter
from the phagolysosomes of macrophages (HRG1) has recently
been described (White et al., 2013). Whether the glycosylated
luminal tail of NCU-G1 might interact directly with HRG1 or offer
protection against lysosomal proteases (Schieweck et al., 2009)
remains to be elucidated. However, we cannot finally rule out that
lipofuscin and iron deposition are rather a consequence than the
cause of liver fibrosis.
In summary, we have created a viable Ncu-g1gt/gt mouse with
spontaneous liver fibrosis as the predominant phenotype. The
condition progresses slowly, but displays all hallmarks of fibrosis at
6 months of age. Elevated markers for oxidative stress and
inflammation were detected in Ncu-g1gt/gt liver, in addition to
increased accumulation of lipofuscin and iron in KCs. Fibrosis has
many etiologies and consists of acute as well as chronic liver
damage. It is well known that reversal of fibrosis is possible if the
cause is remedied; however, that is often not possible. In the
constant search for improved drugs to treat this condition, various
animal models are essential tools. We propose that the Ncu-g1gt/gt
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Fig. 5. Activated fibrogenic response in Ncu-g1gt/gt liver. (A,B) Immunofluorescence image shows CD68- and F4/80-stained KCs (green). Liver sections
were counterstained with DAPI (blue). Infiltrating leukocytes can be seen in Ncu-g1gt/gt liver section (white arrow). CD68-positive cells seem to congregate at
the site of leukocyte infiltration. In Ncu-g1gt/gt liver sections, F4/80-positive cells appear swollen and hypertrophic. Scale bars: 50 μm. (C) qPCR analyses of the
restorative (Cd81) and the pro-inflammatory (Cd86) macrophage markers show elevated expression of only Cd86 in Ncu-g1gt/gt liver. (D,E) Activated KCs
produce pro-fibrogenic cytokines. qPCR analyses show elevated expression of genes characteristic for activated fibrogenesis (Tnf, Pdgfb, Tgfb1, Tgfbr2).
(F) Presence of activated HSCs was indicated by increased expression of genes characteristic for activated HSCs (α-Sma, Igfbp3, Vim). (G) This was
supported by α-Sma staining in liver sections from wild-type (WT) and Ncu-g1gt/gt mice. Note the positive labeling of α-Sma indicating activated HSCs (arrows)
in affected areas. Liver sections were counterstained with hematoxylin. Scale bar: 50 μm. (H) Immunofluorescence imaging shows increased levels of
myeloperoxidase at the protein level in Ncu-g1gt/gt liver (green). Liver sections were counterstained with DAPI (blue). Note the granular staining pattern of
myeloperoxidase, clustering of myeloperoxidase-positive cells and increased levels of invading polymorphonuclear leukocytes with small nuclei. Scale bar: 50
μm. (I) qPCR analyses supported the elevated myeloperoxidase (Mpo) expression in Ncu-g1gt/gt liver. (J) The expression of S100 calcium binding protein A8
(S100a8) was also elevated in Ncu-g1gt/gt liver. (C-F,I,J) n=4, *P<0.05, **P<0.005, ***P<0.001. Values are expressed as mean±s.e.m.
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mouse could be useful in the development of treatments for
attenuation of fibrosis due to chronic liver damage.
MATERIALS AND METHODS
Generation of Ncu-g1gt/gt mice
Embryonic stem cells (ES cells 129S2, P084H04) carrying a gene-trap in
the first intron of the Ncu-g1 gene (RIKEN cDNA 0610031J06 gene) were
purchased from The German Gene-Trap Consortium (Neuherberg,
Germany). The gene-trap leads to a stop in transcription at this point. In
collaboration with the Norwegian Transgenic Centre (Oslo, Norway), ES
cells were injected into C57BL/6 blastocysts and chimeric mice were
obtained. Five chimeric males were mated with C57BL/6 females. The first
litters consisted of 29 pups out of which nine were positive for neomycin
and seven of these were shown to carry the gene-trap by PCR. Two females
and one male were chosen for further breeding and pups were analyzed for
presence of the gene-trap by PCR, using 200 ng of ear genomic DNA and
the primer pairs shown in supplementary material Table S2 to differentiate
between wild-type and gene-trap-carrying mice: FlpROSA, yielding a
product of 811 bp when the gene-trap cassette is present; and NCUG1,
yielding a 562 bp product when the gene-trap cassette is absent. Founders
were selected and mated to yield the F1 generation. Mating resulted in mice
heterozygous for the Ncu-g1 gene modification. Heterozygotes were mated,
leading to the birth of homozygotes. Mice were maintained in an approved
animal facility (National Lab Animal Center, The Norwegian Institute of
Public Health, Oslo, Norway) with access to food and water ad libitum.
Animal handling was according to national laws and regulations.
Analysis of gene expression
RNA extractions from mouse liver, kidney, lung and spleen (n=3) were
carried out according to the manufacturer using RNeasy Plus kit from
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Fig. 6. Intralysosomal accumulation of lipofuscin and iron in Ncu-g1gt/gt KCs. (A) Immunofluorescence image analyses showed colocalization of Lamp1-
coated vesicles (green) and autofluorescence (red) in Ncu-g1gt/gt but not in wild-type (WT) liver. Liver sections were counterstained with DAPI (blue). Scale bar:
20 μm. (B) Representative transmission electron microscopy micrographs of KCs from WT and Ncu-g1gt/gt liver. Large storage vacuoles are visible inside Ncu-
g1gt/gt KCs (arrow) (N, nucleus). Scale bars: 2 μm. (C) Perls’ Prussian blue staining (blue) of liver sections from WT and Ncu-g1gt/gt mice revealed accumulation
of iron (arrow, insert) in Ncu-g1gt/gt KCs. Scale bar: 50 μm. (D) qPCR analyses show elevated expression of genes involved in iron accumulation (Hepcidin1, L-
Ferritin) and iron transport (Ferroportin) in Ncu-g1gt/gt liver. n=4, *P<0.05. Values are expressed as mean±s.e.m.
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Qiagen (Hilden, Germany). Expression of Ncu-g1 mRNA was assessed
using TaqMan gene expression assays for detection of mouse Ncu-g1:
Mm00658309_g1, and mouse Gapdh: Mm99999915_g1 (Life Technologies,
Carlsbad, CA, USA), and LightCycler® 480 Probes Master (Roche Applied
Science, Mannheim, Germany). Signals below the threshold value (cp >40)
were manually set to 40 in the calculations. RNA was extracted from livers
of wild-type and Ncu-g1gt/gt mice (n=3), and gene expression was analyzed
using the Fibrosis (PAMM-120A, Qiagen), Hepatotoxicity (PAMM-093F,
Qiagen), Signal Transduction Pathway Finder (PAMM-014A, Qiagen) and
Oxidative Stress and Antioxidant Defense RT2 ProfilerTM Array (PAMM-
065A, Qiagen), following the manufacturer’s instructions. To verify array
results, and to further elucidate the fibrogenic response, RNA from livers of
wild-type and Ncu-g1gt/gt mice (n=4, age 6 months) was analyzed for relative
gene expression of selected mRNA transcripts by qPCR (supplementary
material Table S3). Analysis was performed using LightCycler® 480 SYBR
Green I Master Mix (Roche Applied Science). Relative gene expression was
calculated using β-actin and eukaryotic translation elongation factor 2 as
reference genes.
Isolation of mouse liver cells from wild-type mice was carried out by the
two-step perfusion method as described (Hansen et al., 2002). Liver
parenchymal and non-parenchymal cells were separated by differential
centrifugation and Pronase E (Merck, Darmstadt, Germany) treatment as
described elsewhere (Berg and Boman, 1973). The expression of Ncu-g1
was analyzed as described above.
Histochemistry
Livers from 6-month-old Ncu-g1gt/gt (n=6) and wild-type (n=3) mice were
collected and fixed in 4% formaldehyde in 0.1 M PBS. Representative tissue
blocks (5 mm thick) were embedded in paraffin, sliced in 4-μm sections and
stained with H&E, Masson-Goldner’s trichrome staining for collagen, or
Perls’ Prussian blue staining for iron according to standard procedures.
Immunohistochemistry
For labeling of α-Sma and active caspase 3, formalin-fixed paraffin-
embedded sections were deparaffinized, rehydrated and demasked in a
microwave oven for 24 minutes in Tris/EDTA buffer (pH 9.1). Rabbit
polyclonal anti-α-Sma (1:500, ab5694, Abcam, Cambridge, MA, USA) and
rabbit polyclonal anti-active caspase 3 (1:500, G7481, Promega, Madison,
WI, USA) were used as antibodies. For labeling of F4/80, formalin-fixed
paraffin-embedded sections were deparaffinized, rehydrated and demasked
in a microwave oven for 24 minutes in Target retrieval solution (pH 6.0-6.2).
Rat monoclonal anti-F4/80 (1:100, 14-4801, eBioscience, San Diego, CA,
USA) and peroxidase-conjugated AffiniPure F(ab′)2 fragment mouse anti-
rat IgG (H+L) (1:100, 212-036-168, Jackson ImmunoResearch Europe Ltd,
Newmarket, Suffolk, UK) were used as primary and secondary antibodies,
respectively.
The antigen-antibody complexes were visualized with Dako Cytomation
Envision+ System-HRP (K4007, DAKO North America Inc., CA, USA)
using 3,3′-diaminobenzidine as the chromogen. The sections were
counterstained with Mayer’s hematoxylin solution.
Immunofluorescence
Formalin-fixed livers were sectioned using a Leica 9000s sliding microtome
(Wetzlar, Germany) into 40-μm-thick free-floating sections. After blocking
with 4% normal goat serum and permeabilization with 0.5% Triton X-100
in 0.1 M phosphate buffer (PB), sections were incubated with appropriate
primary antibodies overnight. Antibodies used for immunofluorescence
were: rat monoclonal anti-CD68 (1:500, FA-11, AbD Serotec, Oxford, UK);
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Fig. 7. Reduced expression of cathepsin D in Ncu-g1gt/gt liver. (A) Western blot analyses of whole liver homogenates show a significantly reduced protein
expression of cathepsin D in Ncu-g1gt/gt liver (n=4, ***P<0.001). Values are expressed as mean±s.e.m. (B) Immunofluorescence image analyzing colocalization
of cathepsin D (green) and the oval cell marker A6 (red). Liver sections were counterstained with DAPI (blue). Cathepsin D does not appear to colocalize with
A6-positive cells in Ncu-g1gt/gt liver (inset). Scale bar: 50 μm.
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rabbit polyclonal anti-myeloperoxidase (1:300, Millipore, Billerica, MA,
USA); rat monoclonal anti-F4/80 (1:25 cell culture supernatant). The
monoclonal antibody against mouse Lamp1 (clone 1D4B) was obtained
from the Developmental Studies Hybridoma Bank developed under the
auspices of the NICHD and maintained by The University of Iowa,
Department of Biology, Iowa City, IA 52242. Rat monoclonal anti-A6 (cell
culture supernatant; 1:25) was a kind gift from Valentina Factor and
described previously (Engelhardt et al., 1990). Cathepsin D antibody was
described previously (Claussen et al., 1997). After washing with 0.25%
Triton X-100 in PB and incubation with Alexa-Fluor-488 or -633 secondary
antibodies (Molecular Probes, Eugene, OR, USA), sections were
counterstained with DAPI and mounted with Mowiol/DABCO. Confocal
laser scanning microscopy was performed on a Leica TCS SP2 microscope
(Wetzlar, Germany).
Transmission electron microscopy (TEM)
Ncu-g1gt/gt and wild-type mice (n=3, age 6 months) were subjected to
perfusion fixation using HEPES buffer (0.1 M, pH 7.2-7.4) with 4%
formaldehyde and 2.5% glutaraldehyde. Livers were cut into tissue blocks of
1 mm3, transferred to new fixative solution and kept at 4°C overnight. The
samples were rinsed 2×10 minutes in 0.1 M sodium cacodylate buffer prior to
post-fixation (2% OsO4 in 0.1 M sodium cacodylate buffer) for 1 hour, and
rinsed 5×10 minutes in distilled water before bulk staining with 1.5% uranyl
acetate [(CH3COO)2UO2.2H2O] in distilled water for 30 minutes in the dark.
Fixed tissue samples were dehydrated in a graded series of ethanol for 10
minutes each (70%, 80%, 90%, 96%), 4×15 minutes in 100% ethanol and
finally 2×10 minutes in propylene oxide. Following dehydration, tissue
samples were infiltrated with epoxy:propylene oxide (1:1) for 30-60 minutes
on a rotary shaker, evaporated overnight, and the following day incubated 1
hour in pure epoxy before embedding in plastic capsules and polymerization
at 60°C. Five tissue blocks were selected per individual mouse. Ultrathin
sections were obtained using a Leica Ultracut S microtome (Leica, Wetzlar,
Germany) with diamond knife. The sections were collected on copper-coated
grids and stained with lead citrate for 20 seconds. All electron micrographs
were obtained with a CM200 transmission microscope (Philips, Amsterdam,
The Netherlands) at 80 kV and at least 20 unique micrographs were analyzed
in order to produce representative figures.
Sirius-red quantification of total liver collagen
Quantification of total collagen content from mouse liver tissue was carried
out by a sirius-red colorimetric plate assay as described (Kliment et al.,
2011). Briefly, livers were homogenized in 10 volumes of CHAPS buffer
(50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 10 mM CHAPS and
protease inhibitors) using an Ultra-Turrax. The samples were diluted using
PBS, dried at 37°C overnight on a microtiter plate, and total liver collagen
content was determined colorimetrically using 0.1% sirius-red stain (Direct
red 80, Sigma-Aldrich, St Louis, MO, USA) in saturated picric acid, and rat
tail collagen (Sigma-Aldrich) as standards.
Western blotting
Liver tritosomes were isolated as described elsewhere (Schieweck et al.,
2009). Tritosome preparations (20 μg protein) were electrophoresed on
NuPAGE® 4-12% Bis-Tris Mini Gels (Life Technologies), and transferred
onto PVDF membranes (Bio-Rad, Hercules, CA, USA). After blocking,
membranes were incubated overnight at 4°C with rabbit anti-NCU-G1
serum (Schieweck et al., 2009) or rabbit anti-Lamp1 (1:1000, C54H11, Cell
Signaling, Beverly, MA, USA). This was followed by 1 hour incubation
with goat anti-rabbit secondary antibody conjugated to horseradish
peroxidase (1:4000, 65-6120, Life Technologies). For liver homogenates,
livers were homogenized in 20 volumes of lysis buffer (tris-buffered saline
containing 1% Triton X-100 and protease inhibitors) by Potter Elvehjem
homogenizer, incubated on ice for 30 minutes with continuous vortexing and
cleared by centrifugation for 20 minutes at 14,000 g. The supernatants were
used for western blotting after separation on 15% SDS-PAGE gels and
transfer onto PVDF membranes (Bio-Rad). After incubation with primary
antibodies overnight [caspase 3: 1:1000, Cell Signaling, Beverly, MA, USA;
cathepsin D: 1:1000 (Claussen et al., 1997); cathepsin B and Gapdh: 1:300
each, Santa Cruz Antibodies] and washing, membranes were incubated for
1 hour with goat anti-rabbit secondary antibody conjugated to horseradish
peroxidase (1:5000, Dianova). Protein bands were visualized using
Amersham ECL Plus Western Blotting Detection Reagents (GE Healthcare,
Pittsburgh, PA, USA).
Enzyme activity assays
Enzymatic activities of lysosomal hydrolases were determined from liver
homogenates (see above) using standard procedures with colorimetric
substrates (p-Nitrophenyl-α-D-mannopyranoside for α-mannosidase and p-
Nitrophenyl N-acetyl-β-D-glucosaminide for β-hexosaminidase). Absorption
of nitrophenolate was determined at 405 nm in a 96-well plate reader. For
cathepsin B determination, protease inhibitors were omitted from the lysis
buffer. Cathepsin B was determined using fluorescence substrate Z-Arg-Arg-
AMC (Bachem, Weil am Rhein, Germany) according to Barrett (Barrett,
1980).
Serum analysis
Coagulated blood samples from wild-type and Ncu-g1gt/gt mice (n=4) were
centrifuged at 1500 g for 20 minutes, and serum ALT and AST activities
were measured at The Central Laboratory, Department of Basic Sciences
and Aquatic Medicine, Norwegian School of Veterinary Science.
Statistical methods
All results are expressed as mean±s.e.m. Genotype distribution was analyzed
using the Chi-square test (Microsoft Excel, Microsoft Corporation,
Redmond, WA, USA). Other data were analyzed using two-tailed t-test
(SigmaPlotTM, Systat Software Inc., Chicago, IL, USA).
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